|Bid||82.41 x 1000|
|Ask||82.45 x 800|
|Day's range||82.10 - 83.19|
|52-week range||52.17 - 85.00|
|PE ratio (TTM)||84.80|
|Earnings date||22 Aug 2018 - 27 Aug 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||82.15|
Veeva Systems (VEEV) today announced that Idorsia Pharmaceuticals Ltd established an integrated development landscape with Veeva Development Cloud. With unified applications for clinical, regulatory, and quality on a single cloud platform, Idorsia now has the technology foundation to accelerate product innovation and support its global growth plans. “With a strong pipeline of innovative new therapies, we needed cutting-edge cloud technology that could scale as we grow,” said Joseph Bejjani, CIO at Idorsia.
Like a winning Major League Baseball club, Federated Kaufmann Small Cap Fund's success owes much to team work.
BARCELONA, Spain--(BUSINESSWIRE)-- Better visibility and improved study execution are top drivers; organizations moving to next-generation clinical applications Over the past year, there has been significant ...
Over the past year, there has been significant industrywide momentum toward streamlining clinical systems and processes, according to one of the largest annual life sciences surveys of clinical operations professionals from Veeva Systems .
Over the past year, there has been significant industrywide momentum toward streamlining clinical systems and processes, according to one of the largest annual life sciences surveys of clinical operations professionals from Veeva Systems (VEEV). The latest findings of the Veeva 2018 Unified Clinical Operations Survey reveal that nearly all (99%) clinical leaders surveyed cite the need to unify their clinical environment. Most (87%) report their organizations are taking action with initiatives planned or underway to unify their clinical operations for improved trial performance.
Veeva Systems (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Veeva Systems Inc (NYSE:VEEV) saw a decent share price growth in the teens level on the NYSE over the last few months. As a large-cap stock with high coverage byRead More...
Veeva Systems (VEEV) today announced that leading pharmaceutical companies and CROs are now using Veeva Vault EDC to improve data management in their clinical trials. In just over a year since the product’s availability, 12 early adopters have initiated studies with Vault EDC, including a top 20 global pharmaceutical company. “The ability to effectively manage clinical data is essential as trials become more complex,” said Alison Liddy, SVP clinical risk and data management at ICON, who is running a trial on behalf of a customer leveraging Veeva Vault EDC.
At the upcoming DIA 2018 Annual Meeting, Tufts Center for the Study of Drug Development (CSDD) will preview its study findings on the root causes for delays and inefficiencies impacting trial timelines. As a follow-up to the 2017 eClinical Landscape Study, sponsored by Veeva Systems (VEEV), Tufts CSDD spoke with more than 40 data management executives about the top challenges and opportunities in clinical data management. Findings indicate there is a significant opportunity to transform data management practices for greater agility and to accelerate adoption of risk-based approaches.
The media went full throttle in covering the exit of centuries-old GE from the Dow Jones industrial average, but the truly dynamic action for investors continued to center on fast-growing companies on the Nasdaq, including PayPal and Alphabet.
Stock futures were little changed. Alibaba, ServiceNow, Red Hat, Veeva Systems are all in buy zones and on the Rising Profit Estimates list.
Veeva Systems Inc. a leading industry cloud provider for life sciences, today announced that Tim Cabral, CFO, will present at the Bank of America Merrill Lynch 2018 Global Technology Conference on Wednesday, June 6, 2018, at 2:20 p.m.
Veeva Systems (VEEV) today announced Veeva Vault Training, a new cloud application to simplify role-based training across life sciences organizations and help quality teams remain audit-ready and compliant. Together with Veeva Vault QMS and Veeva Vault QualityDocs, Veeva will deliver a unified suite of quality applications on a single cloud platform that brings together training with quality processes and document control for seamless, end-to-end quality management.
Here are some things going on today in the world of tech: Shares of streaming pioneer Roku (ROKU) are up $1.61, or 4.5%,% at $37.60, after noted short-selling firm Citron Research announced that it is reversing its short call on the stock—first issued just after the company’s November IPO—after concluding the stock is undervalued relative to peers in the “over the top,” or OTT, video market. In a report posted online, with no byline, the firm notes Roku shares are "trading at the largest discount ever to OTT peers despite being the only OTT pure play that generates ad revenue." The authors point out Roku's multiple of enterprise value to sales relative to Netflix (NFLX) and ad broker Trade Desk (TTD) is so low that Roku "has gone from the most expensive to by far the cheapest" segment play.
The stock market was mixed to close out the week ahead of the three-day Memorial Day weekend. PayPal received an analyst upgrade.
Stock futures rose early Friday. Splunk, Veeva, Ross Stores and Deckers Outdoor closed in buy range, but were active overnight on earnings. Autodesk, near a buy point, also reported earnings.